Boswellia Carterii Extract

Boswellia Carterii Extract is a standardized botanical ingredient derived from the gum resin of Boswellia carterii Birdw., a resin-producing tree traditionally known as frankincense. The extract is produced using food-grade extraction processes and standardized to naturally occurring boswellic acids, the key bioactive constituents of frankincense.

Shaanxi Jiuyuan Biotechnology manufactures Boswellia extract under a strict GMP quality management system, ensuring consistent active content, traceable raw materials, and stable batch-to-batch quality for global customers in the dietary supplement, functional food, and cosmetic industries.

Its main active ingredient is Boswellic acids,including alpha frankincense, beta frankincense, acetyl beta frankincense, and 11 keto beta frankincense.These ingredients have significant anti-inflammatory, antioxidant, anti-tumor, and immune regulatory effects.

Raw Material Sourcing & Control:

The raw frankincense resin used in our extract is carefully selected based on botanical identity, appearance, and purity. Incoming raw materials undergo identity verification and quality screening prior to production, including moisture, ash, and visual inspection, ensuring suitability for standardized extraction.

Botanical Name: Boswellia carterii Birdw.

Family: Burseraceae

Part Used: Gum Resin (Oleo-gum-resin)

Common Name: Frankincense

Boswellia carterii is primarily native to the Arabian Peninsula and East Africa. Its resin has been traded and used for centuries and should be clearly distinguished from Boswellia serrata, a different species commonly used in Indian botanical preparations.

The Boswellic Acid Family

1. AKBA (3-O-Acetyl-11-keto-β-boswellic acid)

AKBA is the most pharmacologically potent boswellic acid and the primary reason Boswellia extract commands premium positioning in the joint health category. Its mechanism is well-characterized:

Selective 5-LOX inhibition - AKBA binds directly to 5-lipoxygenase, blocking the conversion of arachidonic acid to pro-inflammatory leukotrienes (particularly LTB4)

Non-competitive inhibition - AKBA's binding mechanism differs from that of NSAIDs, making it complementary rather than redundant in multi-ingredient formulations

NF-κB modulation - emerging research supports AKBA's ability to downregulate NF-κB signaling, a master regulator of the inflammatory gene expression program

2. KBA (11-keto-β-boswellic acid)

KBA is the non-acetylated precursor to AKBA. It shares the 5-LOX inhibitory mechanism but with lower potency relative to AKBA. KBA contributes meaningfully to the total anti-inflammatory activity of a standardized extract and is typically co-reported with AKBA in quality COAs.

3. α-Boswellic Acid & β-Boswellic Acid

These are the most abundant boswellic acids by mass in most extracts. While their 5-LOX inhibitory activity is weaker than AKBA, they contribute to the overall anti-inflammatory profile and may play roles in gut health and microbiome modulation.

4. Acetyl-α-boswellic Acid (AαBA)

The acetylated form of α-boswellic acid. Present in meaningful concentrations in B. carterii resin and contributes to the total boswellic acid pool reported on COAs.

5. Incensole Acetate

A diterpene compound relatively specific to B. carterii and B. sacra - less prevalent in B. serrata. Emerging research has explored incensole acetate's neuroprotective and anxiolytic properties via TRPV3 channel activation, adding a potential neurological dimension to B. carterii extract that B. serrata does not share.

Compound Summary Table

Boswellia Carterii Extract's well-characterized 5-LOX inhibitory mechanism and strong clinical evidence base make it one of the most versatile and commercially defensible botanical ingredients across multiple high-growth supplement categories.

Production Process (Overview)

Raw Resin
→ Food-grade Extraction
→ Filtration & Centrifugation
→ Concentration
→ Drying
→ Milling & Blending
→ Finished Product Testing

Jiuyuan Manufacturing Advantages

• GMP-certified production workshops covering over 70,000 m²
• Fully automated centrifugation and filtration systems for high extract clarity
• Particle size control from 8–350 mesh, tailored to customer requirements
• Dedicated in-house quality control and R&D teams

Quality control for Boswellia Carterii Extract is more demanding than for many botanical ingredients - because the resin matrix is chemically complex, AKBA is present at low natural concentrations, and adulteration with lower-grade Boswellia species or synthetic boswellic acid analogues is a documented industry problem.

Our QC program is built around three non-negotiable principles: species authentication, compound-specific quantification, and batch-level traceability.

In-House Testing Capabilities

What Ships With Every Order

✅ Batch-specific Certificate of Analysis (COA)

✅ MSDS / Safety Data Sheet

✅ Heavy metals report

✅ Microbiological testing report

✅ Botanical identity verification document

✅ Pesticide residue report (on request)

✅ Allergen and GMO declaration

✅ Country of origin documentation

We retain samples from every commercial batch for 24 months. Independent third-party verification at ISO 17025-accredited laboratories is actively supported.

JIUYUAN BIOTECH only selects high-quality frankincense as raw materials, and adopts extraction methods such as ultrasonic assisted extraction and microwave extraction, the latest purification technology, and strict quality control procedures to ensure that each batch of products meets international standards. In addition, the green and environmentally friendly production process is adopted to reduce solvent residues and environmental pollution, in line with the requirements of sustainable development. These advantages not only ensure the high quality and safety of the products, but also improve production efficiency and market competitiveness, providing a solid foundation for the wide application of the products.

We offer three standard packaging formats, each designed around a specific order volume and transit risk profile:

Who Should Source This Ingredient?

Boswellia Carterii Extract is the right fit for:

• Joint health supplement brands building osteoarthritis, arthritis, or mobility SKUs
• Sports nutrition companies targeting exercise-induced inflammation and recovery
• Respiratory health formulators addressing leukotriene-mediated airway conditions
• Gut health brands exploring inflammatory bowel and intestinal integrity applications
• Healthy aging and longevity brands building systemic inflammation management products
• Cosmetic and topical formulators targeting skin anti-inflammatory and anti-aging claims
• Private label manufacturers seeking a well-documented, clinically referenced botanical ingredient
• Distributors serving pharmacy, health food, and specialty retail channels in the US, EU, and Middle East

Ordering Process

1. Request a sample - 50 g to 200 g samples available for formulation trials and third-party verification
2. Review COA and documentation - full analytical package including species authentication provided before order placement
3. Select grade - standard grades (BC-BA65, BC-AKBA10, BC-AKBA20, BC-AKBA30) ship within 7–10 business days
4. Place commercial order - MOQ from 25 kg for standard grades
5. Receive with full documentation - COA, MSDS, botanical ID, and compliance documents ship with every order

Packaging Options

Shipping & Lead Times

• Sample orders: 3–5 business days (DHL / FedEx express)
• Standard commercial orders: 7–10 business days after payment confirmation
• Custom AKBA-enriched grades: 15–20 business days
• Incoterms: EXW, FOB, CIF available

Q1: What is the difference between Boswellia carterii and Boswellia serrata extract?

Both species produce frankincense resin and contain boswellic acids - but their chemical profiles differ in meaningful ways. B. serrata is native to India and is the most extensively studied species in clinical trials for joint health. B. carterii is native to Somalia and East Africa and shares the core boswellic acid profile but additionally contains incensole acetate - a diterpene compound with emerging neuroprotective and anxiolytic research that is largely absent in B. serrata. For formulators targeting joint health specifically, both species are relevant. For formulators interested in neurological or mood applications, B. carterii offers a distinct advantage.

Q2: Why does AKBA content matter more than total boswellic acids?

Total boswellic acids is a class measurement - it includes all boswellic acid variants, some of which have minimal 5-LOX inhibitory activity. AKBA is the specific compound with the strongest, most selective 5-LOX inhibitory mechanism and the most direct clinical evidence. A product declaring "65% boswellic acids" with only 3% AKBA delivers a very different pharmacological profile than one with 65% boswellic acids and 20% AKBA. Always ask your supplier to declare AKBA content separately - and verify it by HPLC.

Q3: What is the recommended dosage for joint health applications?

Published clinical research and commercial formulation practice generally support a daily dose of 100–400 mg of standardized Boswellia extract for joint health applications, with the effective dose varying by AKBA concentration. A clinical study published in Nutraceuticals World confirmed that 100 mg of a standardized Boswellia extract was associated with improved joint comfort measures - though higher AKBA grades may allow lower absolute doses to achieve equivalent AKBA delivery. Work with your clinical or regulatory team to establish the appropriate dose for your specific product and claim.

Q4: Is Boswellia Carterii Extract safe for long-term use?

Boswellia resin has a documented history of human use spanning thousands of years. Modern safety studies support its tolerability at standard supplement doses. Unlike NSAIDs, boswellic acids do not inhibit COX-1 and are not associated with gastrointestinal ulceration at typical supplement doses. However, as with any bioactive ingredient, we recommend consulting with your regulatory and clinical team for long-term use claims and specific population considerations.

Q5: Can Boswellia Carterii Extract be combined with other joint health ingredients?

Yes - and combination formulas are among the most commercially successful applications. Boswellia extract pairs particularly well with:

Curcumin / turmeric extract - complementary anti-inflammatory mechanisms (5-LOX + COX-2)

Type II collagen (UC-II) - structural cartilage support alongside anti-inflammatory activity

Hyaluronic acid - synovial fluid support

Glucosamine / chondroitin - cartilage matrix support

Our technical team can advise on compatibility, stability, and recommended ratios for multi-ingredient joint health formulas.

Q6: Do you offer organic-certified Boswellia Carterii Extract?

Yes. USDA NOP and EU Organic certified grades are available. B. carterii resin is wild-harvested from natural forest stands in Somalia and Ethiopia - regions where synthetic agricultural inputs are not used in the harvesting process. Organic certification documentation is available upon request. Lead times for organic grades are slightly longer - please confirm availability at the time of inquiry.

Q7: How do you prevent adulteration or species substitution in your supply chain?

Species adulteration is a genuine and documented problem in the Boswellia ingredient market. Our mitigation protocol operates at three levels:

• Supplier qualification - direct relationships with verified resin collectors and regional aggregators in Somalia and Ethiopia, with documented supply chain traceability
• Incoming lot authentication - every raw material lot undergoes TLC fingerprinting and botanical identity verification before processing
• Finished product HPLC profiling - the boswellic acid chromatographic fingerprint of B. carterii differs from B. serrata and other species; our HPLC method detects species-level profile deviations

We provide the full authentication documentation package with every commercial order.

Q8: What regulatory status does Boswellia Carterii Extract hold in the US and EU?

In the United States, Boswellia carterii extract is used as a dietary supplement ingredient under DSHEA. It is not currently classified as a Novel Food in the EU for standard resin extract applications, but regulatory status can vary by specific formulation, application, and claim. We provide full botanical identity documentation, safety data, and historical use records to support your regulatory submissions in any target market. Always consult your regulatory affairs team for market-specific compliance guidance.

At Jiuyuan Biotech, we supply Boswellia Carterii Extract in HPLC-verified, species-authenticated grades - from BC-BA65 to BC-AKBA30 - backed by 12 international certifications, batch-specific COAs, and a technical team that understands the difference between a genuine AKBA number and a marketing claim.

Whether you are building a clinical-grade joint health formula, a sports recovery product, or a premium anti-inflammatory supplement, we have the grade, the documentation, and the supply chain integrity to support your formulation from sample to commercial scale.

📧 Email us: info@jiuybiotech.com

🌐 Visit us: www.jiuyuanbio.com

Sample requests, COA downloads, and technical consultations are available at no charge. Our team typically responds within 24 business hours.